Eventide Asset Management, LLC Fennec Pharmaceuticals Inc. Transaction History

Eventide Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.96 - $7.85 $6.2 Million - $8.16 Million	-1,040,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$6.21 - $8.68 $496,800 - $694,400	-80,000 Reduced 7.14%	1,040,000 $6.46 Million
Q2 2020 Aug 14, 2020	BUY	$5.43 - $9.39 $2.17 Million - $3.76 Million	400,000 Added 55.56%	1,120,000 $9.35 Million
Q4 2018 Feb 14, 2019	SELL	$5.37 - $8.39 $113,709 - $177,658	-21,175 Reduced 2.86%	720,000 $4.59 Million
Q4 2017 Feb 14, 2018	BUY	$8.9 - $12.35 $6.6 Million - $9.15 Million	741,175	741,175 $7.39 Million

14.9M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $160M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.